Literature DB >> 31669590

Aspirin and its pleiotropic application.

Jolanta Hybiak1, Izabela Broniarek2, Gerard Kiryczyński3, Laura D Los4, Jakub Rosik3, Filip Machaj3, Hubert Sławiński5, Kornelia Jankowska3, Elżbieta Urasińska3.   

Abstract

Aspirin (acetylsalicylic acid), the oldest synthetic drug, was originally used as an anti-inflammatory medication. Being an irreversible inhibitor of COX (prostaglandin-endoperoxide synthase) enzymes that produce precursors for prostaglandins and thromboxanes, it has gradually found several other applications. Sometimes these applications are unrelated to its original purpose for example its use as an anticoagulant. Applications such as these have opened opportunities for new treatments. In this case, it has been tested in patients with cardiovascular disease to reduce the risk of myocardial infarct. Its function as an anticoagulant has also been explored in the prophylaxis and treatment of pre-eclampsia, where due to its anti-inflammatory properties, aspirin intake may be used to reduce the risk of colorectal cancer. It is important to always consider both the risks and benefits of aspirin's application. This is especially important for proposed use in the prevention and treatment of neurologic ailments like Alzheimer's disease, or in the prophylaxis of myocardial infarct. In such cases, the decision if aspirin should be applied, and at what dose may be guided by specific molecular markers. In this revived paper, the pleiotropic application of aspirin is summarized.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticoagulant; Aspirin; Cancer; Cardiovascular; Cyclooxygenase; Pre-eclampsia

Mesh:

Substances:

Year:  2019        PMID: 31669590     DOI: 10.1016/j.ejphar.2019.172762

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Huayu Wan Prevents Lewis Lung Cancer Metastasis in Mice via the Platelet Pathway.

Authors:  Yunfei Ma; Guangda Li; Xu Sun; Kexin Cao; Xiaomin Wang; Guowang Yang; Mingwei Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-27       Impact factor: 2.629

2.  Analysis of Adverse Reactions of Aspirin in Prophylaxis Medication Based on FAERS Database.

Authors:  Weidong Ren; Weihua Wang; Yanli Guo
Journal:  Comput Math Methods Med       Date:  2022-05-26       Impact factor: 2.809

3.  Aspirin in people with dementia, long-term benefits, and harms: a systematic review.

Authors:  Katrina A S Davis; Delia Bishara; Mariam Molokhia; Christoph Mueller; Gayan Perera; Robert J Stewart
Journal:  Eur J Clin Pharmacol       Date:  2021-01-22       Impact factor: 2.953

4.  Evaluation of efficacy and safety of aspirin combination treatment in treating patients with coronary heart disease: A protocol for systematic review and meta-analysis.

Authors:  Xueling Wang; Lin Han; Jiyuan Yang
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

5.  Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development.

Authors:  Xiyun Xiao; Saitian Zeng; Yanying Li; Lingling Li; Jiyan Zhang
Journal:  J Oncol       Date:  2022-03-29       Impact factor: 4.375

6.  Aspirin relieves the calcification of aortic smooth muscle cells by enhancing the heat shock response.

Authors:  Quanquan Shen; Qian Chen; Yang Liu; Xiang Xue; Xiaogang Shen; Qiang He; Guokun Wang; Fei Han
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 7.  Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Hang Yin; Anhua Shi; Junzi Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-08       Impact factor: 3.249

8.  Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease.

Authors:  Lijie Wang; Xiaoqin Tang
Journal:  Comput Math Methods Med       Date:  2022-07-18       Impact factor: 2.809

Review 9.  Lynch Syndrome: From Carcinogenesis to Prevention Interventions.

Authors:  Donatella Gambini; Stefano Ferrero; Elisabetta Kuhn
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

Review 10.  Lipids and Antiplatelet Therapy: Important Considerations and Future Perspectives.

Authors:  Nina Đukanović; Slobodan Obradović; Marija Zdravković; Siniša Đurašević; Maja Stojković; Tomislav Tosti; Nebojša Jasnić; Jelena Đorđević; Zoran Todorović
Journal:  Int J Mol Sci       Date:  2021-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.